切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2012, Vol. 01 ›› Issue (03) : 169 -174. doi: 10.3877/cma.j.issn.2095-3232.2012.03.005

所属专题: 文献

临床研究

选择性肝静脉血流阻断术在肝血管瘤切除术中的应用
杨远1, 周伟平1,(), 傅思源1, 汪珍光1, 顾方明1, 吴孟超1   
  1. 1. 200438 上海,第二军医大学附属东方肝胆外科医院肝外三科
  • 收稿日期:2012-08-04 出版日期:2012-12-10
  • 通信作者: 周伟平
  • 基金资助:
    国家十二五科技重大专项(2012ZX10002010、2012ZX10002016); 国家自然科学基金(30921006)

Application of selective hepatic vascular exclusion in hepatectomy for liver hemangioma

Yuan YANG1, Wei-ping ZHOU1,(), Si-yuan FU1, Zhen-guang WANG1, Fang-ming GU1, Meng-chao WU1   

  1. 1. The Third Department of Hepatic Surgery, East Hepatobilliary Surgery Hospital, Shanghai 200438, China
  • Received:2012-08-04 Published:2012-12-10
  • Corresponding author: Wei-ping ZHOU
  • About author:
    Corresponding author: ZHOU Wei-ping, Email:
引用本文:

杨远, 周伟平, 傅思源, 汪珍光, 顾方明, 吴孟超. 选择性肝静脉血流阻断术在肝血管瘤切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2012, 01(03): 169-174.

Yuan YANG, Wei-ping ZHOU, Si-yuan FU, Zhen-guang WANG, Fang-ming GU, Meng-chao WU. Application of selective hepatic vascular exclusion in hepatectomy for liver hemangioma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2012, 01(03): 169-174.

目的

探讨选择性肝静脉血流阻断术(SHVE)在肝血管瘤切除术中的临床应用价值。

方法

本回顾性研究对象为2003年1月至2010年12月在上海第二军医大学附属东方肝胆外科医院收治的肿瘤直径>5 cm,且肿瘤位于肝静脉、下腔静脉结合部,至少压迫1支主肝静脉(肝左、中、右静脉)的232例肝血管瘤切除术患者。患者均签署知情同意书,符合医学伦理学规定。根据肝血流阻断方法将患者分为SHVE组和Pringle肝门血流阻断组(Pringle组)。SHVE组首先采用Pringle第一肝门血流阻断,术中采用肝静脉止血带阻断和Satinsky钳阻断两种方式。SHVE组92例,男性41例,女性51例,平均年龄45岁;Pringle组140例,男性62例,女性78例,平均年龄43岁。记录两组患者的手术时间、肝脏热缺血时间、术中出血量、输血量、术后重症监护病房(ICU)监护时间及术后住院时间,观察术中、术后并发症及术中改用全肝血流阻断(THVE)、再次手术及死亡发生情况。采用t检验或秩和检验比较两组患者手术时间、肝脏热缺血时间、术中出血量、输血量、术后ICU监护时间及术后住院时间,采用χ2检验和Fisher确切概率法比较术中、术后并发症及改用THVE、再次手术及死亡发生情况。

结果

SHVE组患者手术时间(140±65)min、术中出血量300~1 600(600)ml、输血量0~8(2)U,Pringle组分别为(127±40)min、500~7 000(1 000)ml、0~33(4)U,各项指标比较差异有统计学意义(P<0.05~P<0.01)。SHVE组中无输血者占70%(64/92),Pringle组占46%(65/140),比较差异有统计学意义(χ2=12.0,P<0.01)。SHVE组主肝静脉撕裂者占13%(12/92),大出血者占7%(6/92),无空气栓塞;Pringle组主肝静脉撕裂者占12%(17/140),大出血者占19%(27/140),发生空气栓塞者占4%(5/140),两组大出血发生率比较差异有统计学意义(χ2=7.41,P<0.01)。SHVE组无改用THVE者,Pringle组10例改用THVE行肝静脉修补术,两组比较差异有统计学意义(P<0.01)。SHVE组术后ICU监护时间和术后住院时间比较差异无统计学意义(Z=0.87、0.34,均为P>0.05)。SHVE组和Pringle组术后并发症总体发生率分别为17%(16/92)和30%(42/140),两组比较差异有统计学意义(χ2=4.33,P<0.05);两组大出血、肝衰竭、多器官功能障碍综合征(MODS)、胆漏、腹腔感染和胸腔积液发生率比较差异均无统计学意义(均为P>0.05)。两组各有2例患者因肝创面出血再次手术。SHVE组无发生手术相关死亡,Pringle组2例死亡,分别死于空气栓塞及MODS,两组手术相关死亡率比较差异亦无统计学意义(P=0.67)。

结论

对位于肝静脉、下腔静脉结合部肝血管瘤行切除手术时,SHVE在控制因肝静脉撕裂导致的大出血及预防术后并发症等方面具有一定优势,能明显减少术中出血量及降低术后并发症的发生率。

Objective

To assess the application value of selective hepatic vascular exclusion (SHVE) in the resection for liver hemangioma.

Methods

Two hundred and thirty-two patients with liver hemangioma were included in this retrospective study. All the patients underwent liver hemangioma resection from January 2003 to December 2010 in the East Hepatobilliary Surgery Hospital with the tumor size over 5 cm and located in the junction of hepatic veins and postcava and oppressing at least one of the three major hepatic veins (right, middle or left). Local ethical committee approval was received and that the informed consent of all participating subjects was obtained. The patients were divided into SHVE group and Pringle maneuver (Pringle) group according to the methods vascular of occlusion. Pringle maneuver was conducted primarily in the SHVE group and hepatic vein tourniquet and Satinsky clamp were applied during the operation. In the SHVE group, there were 41 males and 51 females with average age of 45 years old. In the Pringle group, there were 61 males and 78 females with average age of 43 years old. The operation time, liver warm ischemia time, blood loss and transfusion during the operation, the postoperative Intensive Care Unit (ICU) stay and hospital stay were recorded and compared using the t test or Wilcoxon test. The complications during and after the operation, resorting to total hepatic vascular exclusion (THVE), reoperation and death were monitored and were compared using the χ2 test or Fisher exact test.

Results

In the SHVE group, the median operation time was (140±65) min, the blood loss during the operation was 300-1 600 (600 ml), the blood transfusion was 0-8 (2) units. However, the corresponding indexes were (127±40) min、500-7 000 (1 000) ml、0-33 (4) unites respectively in the Pringle group. There were significant differences between 2 groups in each index (P<0.05, P<0.01). The percentage of patients without a blood transfusion in the SHVE group was 70%(64/92) and 46%(65/140) in the Pringle group. There were significant differences between 2 groups(χ2=12.0, P<0.01). The percentages of patients in the SHVE group with lacerated major hepatic veins and massive blood loss were 13%(12/92) and 7%(6/92) respectively. And no air embolism occurred. While in the Pringle group, the percentages of patients lacerated major hepatic veins and massive blood loss were 12%(17/140) and 19%(27/140) respeetively. Five patients (5/140, 4%) in the Pringle group developed air embolism. There were significant differences between 2 groups in the incidence of massive blood loss(χ2=7.41, P<0.01). There were no patients resorted to THVE in the SHVE group while 10 cases converted to THVE in the Pringle group. There were significant differences between 2 groups(P<0.01). There was no significant difference between 2 groups in the postoperative ICU stay and hospital stay (Z=0.87, 0.34; all in P>0.05) . The incidence of postoperative complications in the SHVE group and Pringle group were 17(16/92) and 31%(43/140) respectively. There were significant differences between 2 groups(χ2=4.33, P<0.01). There was no significant difference between 2 groups in the incidence of massive blood loss, liver failure, multiple organ dysfunction syndrome(MODS), bile leak, abdominal infection, pleural effusion (all in P>0.05). Two patients underwent reoperation in both groups for the bleeding of liver wounds. No death was observed in the SHVE group. Two cases died of air embolism and MODS respectively in the Pringle group. There was also no significant difference between 2 groups in the operative mortality.

Conclusions

In the hepatectomy for liver hemangioma located in the junction of hepatic veins and postcava, SHVE has some advantages in controlling the massive blood loss of lacerated hepatic veins and preventing the postoperative complications. It can reduce the intraoperative bleeding and the incidence of postoperative complications.

表1 SHVE组与Pringle组患者的手术情况比较
表2 SHVE组与Pringle组患者术后并发症发生情况比较[例(%)]
[1]
Erdogan D, Busch OR, van Delden OM, et al. Management of liver hemangiomas according to size and symptoms. J Gastroenterol Hepatol, 2007, 22(11):1953-1958.
[2]
Fu XH, Lai EC, Yao XP, et al. Enucleation of liver hemangiomas: is there a difference in surgical outcomes for centrally or peripherally located lesions? Am J Surg, 2009, 198(2):184-187.
[3]
Schnelldorfer T, Ware AL, Smoot R, et al. Management of giant hemangioma of the liver: resection versus observation. J Am Coll Surg, 2010, 211(6):724-730.
[4]
Xia F, Lau WY, Qian C, et al. Surgical treatment of giant liver hemangiomas: enucleation with continuous occlusion of hepatic artery proper and intermittent Pringle maneuver. World J Surg, 2010, 34(9):2162-2167.
[5]
Hamaloglu E, Altun H, Ozdemir A, et al. Giant liver hemangioma: therapy by enucleation or liver resection. World J Surg, 2005, 29(7):890-893.
[6]
Zhang J, Lai EC, Zhou WP, et al. Selective hepatic vascular exclusion versus Pringle manoeuvre in liver resection for tumours encroaching on major hepatic veins. Br J Surg,2012, 99(7):973-977.
[7]
Torzilli G, Makuuchi M, Midorikawa Y, et al. Liver resection without total vascular exclusion: hazardous or beneficial? an analysis of our experience. Ann Surg, 2001, 233(2):167-175.
[8]
Fu SY, Lai EC, Li AJ, et al. Liver resection with selective hepatic vascular exclusion: a cohort study. Ann Surg, 2009, 249(4):624-627.
[9]
Fu SY, Lau WY, Li AJ, et al. Liver resection under total vascular exclusion with or without preceding Pringle manoeuvre. Br J Surg, 2010, 97(1):50-55.
[10]
Zhou W, Li A, Pan Z, et al. Selective hepatic vascular exclusion and Pringle maneuver: a comparative study in liver resection. Eur J Surg Oncol, 2008, 34(1):49-54.
[11]
Smyrniotis VE, Kostopanagiotou GG, Gamaletsos EL, et al. Total versus selective hepatic vascular exclusion in major liver resections. Am J Surg, 2002, 183(2):173-178.
[12]
Smyrniotis VE, Kostopanagiotou GG, Contis JC, et al. Selective hepatic vascular exclusion versus Pringle maneuver in major liver resections: prospective study. World J Surg, 2003, 27(7):765-769.
[13]
Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg, 2005, 242(6):824-828.
[14]
Dixon E, Vollmer CM Jr, Bathe OF, et al. Vascular occlusion to decrease blood loss during hepatic resection. Am J Surg, 2005, 190(1):75-86.
[15]
Cherqui D, Malassagne B, Colau PI, et al. Hepatic vascular exclusion with preservation of the caval flow for liver resections. Ann Surg, 1999, 230(1):24-30.
[16]
Berney T, Mentha G, Morel P. Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Br J Surg, 1998, 85(4):485-488.
[17]
Batignani G, Zuckermann M. Inferior approach for the isolation of the left-middle hepatic veins in liver resections: a safe way. Arch Surg, 2005, 140(10):968-971.
[18]
Kimura F, Miyazaki M, Suwa T, et al. Evaluation of total hepatic vascular exclusion and pringle maneuver in liver resection. Hepatogastroenterology, 2002, 49(43):225-230.
[19]
Li A, Pan Z, Zhou W, et al. Superior approach for the exclusion of hepatic veins in major liver resection: a safe and easy technique. Surg Today, 2009, 39(3):269-273.
[20]
Li AJ, Pan ZY, Zhou WP, et al. Comparison of two methods of selective hepatic vascular exclusion for liver resection involving the roots of the hepatic veins. J Gastrointest Surg, 2008, 12(8):1383-1390.
[21]
Pan ZY, Yang Y, Zhou WP, et al. Clinical application of hepatic venous occlusion for hepatectomy. Chin Med J, 2008, 121(9):806-810.
[1] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[2] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[3] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[4] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[5] 陈忠垚, 陈胜灯, 李秋. 不同手术时机对原发性肝癌自发破裂出血患者远期预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 518-521.
[6] 李婷婷, 吴荷玉, 张悦, 程康, 张晓芳, 程娅婵. 复合保温策略在老年腹腔镜解剖性肝切除术中的应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 522-525.
[7] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[8] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[9] 马俊永, 王毅州, 李锡锋, 吴雅丽, 张小峰. 浅谈腹腔镜肝切除术出血防控策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 495-498.
[10] 李双喜, 胡宗凯, 赵静, 黄洁. 肝血管瘤治疗指征及治疗策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 504-510.
[11] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[12] 张海涛, 贾哲, 马超, 张其坤, 武聚山, 郭庆良, 曾道炳, 栗光明, 王孟龙. 手术切除与射频消融治疗血管周围型单发小肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 523-527.
[13] 吕瑶, 张婵, 陈建华, 张鸣青. 压力控制容量保证通气模式在腹腔镜肝细胞癌切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 528-533.
[14] 孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇. ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 557-561.
[15] 费发珠, 张帅, 刘发蓉, 芦佳骏, 任宾, 樊海宁. 三维可视化联合术中ICG荧光引导腹腔镜肝包虫病切除术一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 577-580.
阅读次数
全文


摘要